Subcutaneous Methylnaltrexone Provides Long-Term Laxation in Patients with Chronic Non-Malignant Pain and Opioid-Induced Constipation

被引：0
|
作者：
Webster, L. R. [1 ]
Michna, E. [2 ]
Khan, A. [3 ]
Maller, E. [4 ]
Tzanis, E. [4 ]
Israel, R. [5 ]
机构：
[1] Lifetree Clin Res & Pain Clin, Salt Lake City, UT USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] NW Clin Res, Bellevue, WA USA
[4] Wyeth Res, Collegeville, PA USA
[5] Progen Pharmaceut Inc, Tarrytown, NY USA
来源：
NEUROGASTROENTEROLOGY AND MOTILITY | 2011年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
153
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [41] The Evolving Role of Long-Term Pharmacotherapy for Opioid-Induced Constipation in Patients Being Treated for Noncancer Pain
    Bowers, Brandi L.
    Crannage, Andrew J.
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (05) : 558 - 567
  • [42] Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation
    Webster, L.
    Chey, W. D.
    Tack, J.
    Lappalainen, J.
    Diva, U.
    Sostek, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (07) : 771 - 779
  • [43] Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients
    Habeeb, Ehsan A.
    Tran, Lena K.
    Goodberlet, Melanie Z.
    Lupi, Kenneth E.
    DeGrado, Jeremy R.
    Dube, Kevin M.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (07) : 762 - 768
  • [44] Effectiveness of Methylnaltrexone Bromide as a Treatment for Opioid-Induced Constipation in NSCLC Patients
    Dimitroulis, Ioannis A.
    Stamou, Panagiota
    Liapikou, Adamantia
    Toumbis, Michail
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (10) : S230 - S231
  • [45] The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation
    Liao, Solomon S.
    Slatkin, Neal E.
    Stambler, Nancy
    DRUGS & AGING, 2021, 38 (06) : 503 - 511
  • [46] Treatment with Methylnaltrexone in Patients with Opioid-Induced Constipation with or Without Active Cancer
    Chamberlain, Bruce
    Rhiner, Michelle
    Slatkin, Neal
    Stambler, Nancy
    Israel, Robert
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (02) : 487 - 487
  • [47] Effect of subcutaneous methylnaltrexone on patient-reported outcomes in advanced illness patients with opioid-induced constipation
    Peppin, J.
    Pappagallo, M.
    Barrett, A.
    Bortey, E.
    Paterson, C.
    Forbes, W.
    JOURNAL OF PAIN, 2013, 14 (04): : S62 - S62
  • [48] Effectiveness of Methylnaltrexone Bromide in Opioid-Induced Constipation in Advanced NSCLC Patients
    Dimitroulis, I.
    Peristeris, P.
    Toumbis, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2232 - S2232
  • [49] Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
    Rauck, Richard
    Slatkin, Neal E.
    Stambler, Nancy
    Harper, Joseph R.
    Israel, Robert J.
    PAIN PRACTICE, 2017, 17 (06) : 820 - 828
  • [50] Naloxegol versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients
    Tobben, Daniel
    Carpenter, Sheniece
    Kolar, Rachel
    Merritt, Tyler
    Young, Tramaine
    Hauser, Paloma
    Collier, Tia
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (07) : 678 - 684
12345